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Abstract
We investigated the behavioral significance of fast synaptic inhibition by abc2-type GABAA receptors on parvalbumin (Pv)
cells. The GABAA receptor c2 subunit gene was selectively inactivated in Pv-positive neurons by Cre/loxP recombination.
The resulting Pv-Dc2 mice were relatively healthy in the first postnatal weeks; but then as Cre started to be expressed, the
mice progressively developed wide-ranging phenotypic alterations including low body weight, motor deficits and tremor,
decreased anxiety levels, decreased pain sensitivity and deficient prepulse inhibition of the acoustic startle reflex and
impaired spatial learning. Nevertheless, the deletion was not lethal, and mice did not show increased mortality even after
one year. Autoradiography with t-butylbicyclophosphoro[35S]thionate suggested an increased amount of GABAA receptors
with only a and b subunits in central nervous system regions that contained high levels of parvalbumin neurons. Using BAC-
transgenesis, we reduced some of the Pv-Dc2 phenotype by selectively re-expressing the wild-type c2 subunit back into
some Pv cells (reticular thalamic neurons and cerebellar Pv-positive neurons). This produced less severe impairments of
motor skills and spatial learning compared with Pv-Dc2 mice, but all other deficits remained. Our results reveal the
widespread significance of fast GABAergic inhibition onto Pv-positive neurons for diverse behavioral modalities, such as
motor coordination, sensorimotor integration, emotional behavior and nociception.
Citation: Leppa¨ E, Linden A-M, Vekovischeva OY, Swinny JD, Rantanen V, et al. (2011) Removal of GABAA Receptor c2 Subunits from Parvalbumin Neurons Causes
Wide-Ranging Behavioral Alterations. PLoS ONE 6(9): e24159. doi:10.1371/journal.pone.0024159
Editor: Izumi Sugihara, Tokyo Medical and Dental University, Japan
Received May 24, 2011; Accepted August 1, 2011; Published September 2, 2011
Copyright:  2011 Leppa¨ et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Finnish Graduate School of Neuroscience (EL), the Academy of Finland (ERK), the Sigrid Juselius Foundation (ERK), the
Volkswagen Foundation I/78 554 (ERK & WW), the Deutsche Forschungsgemeinschaft WI 1951/2 (PW & WW), and the Medical Research Council G0601498 (PW &
WW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: esa.korpi@helsinki.fi (ERK); w.wisden@imperial.ac.uk (WW)
¤a Current address: Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, United Kingdom
¤b Current address: Department of Life Sciences, Imperial College London, South Kensington, London, United Kingdom
Introduction
Parvalbumin (Pv)-positive neurons, with their diverse morphol-
ogies and firing patterns, contribute to neuronal network function
throughout the central nervous system [1,2,3,4,5]. Disturbances in
Pv cell activity in particular brain areas, such as frontal cortex,
hippocampus or cerebellum, can lead to dysfunctional information
processing [6,7,8,9,10,11,12,13]. Mostly, Pv-positive neurons
release GABA, either as interneurons (e.g. cortical basket or axo-
axonic cells) or projection neurons (e.g. cerebellar Purkinje cells or
reticular thalamic neurons). In all cases GABAergic Pv cells,
because they themselves receive inhibition from each other and
other types of GABA neurons, participate in complex loops of
feed-forward and feedback inhibition [6,14]; a minority of Pv cells,
however, are glutamatergic e.g. some cortico-striatal projection
neurons [15,16,17]. Some brain regions, such as the cerebellar
cortex and the reticular thalamic nucleus, contain mostly or only
Pv-positive cells; in other brain areas, such as the caudate-
putamen, colliculi, deep cerebellar nuclei, neocortex and hippo-
campus, Pv cell types form a minority, but they are important for
organizing general network activity [14].
Given the ubiquity of both GABAergic transmission in the CNS
and the expression of the GABAA receptor c2 subunit gene
[18,19], it seems likely that most, if not all, Pv cell types receive fast
synaptic inhibition via abc2 type GABAA receptors. Within such a
typical GABAA receptor complex, the c2 subunit allows allosteric
modulation of GABAA receptor complexes by drugs such as
benzodiazepines and b-carbolines [18]. More fundamentally, since
the c2 subunit targets the GABAA receptor to the synapse and
provides the full single channel conductance [20,21,22], knock-out
of the c2 subunit ablates fast synaptic inhibition [6,11,12,23] with
the remaining ab GABAA receptors providing receptors of low
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conductance and short open duration [21,24]. Indeed, the
functions of abc2 GABAA receptors are so essential for CNS
circuitry, that total knockout of the c2 subunit is lethal in the early
postnatal period [25]. Even without a total knockout, if the level of
c2 protein is reduced (heterozygote c2 knockout or neo gene
insertion into an intron) neurological and behavioral phenotypes
appear [26,27,28]. The haplo-insufficiency implies that healthy
neurons normally have sufficient, but not excess, c2 protein levels.
In contrast to the c2 gene total knockouts, cell-type-selective
inactivations of the c2 subunit gene give, as expected, a range of
network and behavioral phenotypes, some major and lethal, some
subtle, depending on cell type and age [6,11,12,22,29,30].
Furthermore, removing c2 from neurons is not necessarily
excitatory in the sense that it makes the cells fire more action
potentials; Purkinje neurons, for example, have an intrinsic
pacemaker. Removing c2 and fast synaptic inhibition from these
Pv-positive cells makes them fire action potentials more regularly,
but counter-intuitively, they do not fire more (see [12]). Finally,
dominant negative mutations (R43Q) in the c2 subunit gene can
produce epilepsy in human neonates and adults [31,32].
In Pv-Dc2 mice, the c2 subunit gene was inactivated via Cre/
loxP recombination in Pv-neurons [6]. In electrophysiological
recordings from Pv-Dc2 mice fast IPSCs are missing from
hippocampal Pv-interneurons. Similarly, in cerebellar Purkinje
cell-Dc2 mice (PC-Dc2) fast IPSCs are missing from Purkinje cells
after removal of the c2 subunit; only small, slow inhibitory
currents remain, which may be due to spillover of GABA from the
synapse to low conductance extrasynaptic ab subunit-containing
receptors [6,11,12]. In Pv-Dc2 mice, the lack of fast synaptic
inhibition onto Pv-neurons disrupts hippocampal network oscilla-
tions: theta band oscillations are reduced several fold in power and
have reduced frequency, and although gamma band oscillations
are intact with respect to frequency and power, the coupling
between theta and gamma band oscillations is disrupted [6]. In
PC-Dc2 mice, Purkinje cells show altered firing patterns and the
mice cannot consolidate new motor memories [12].
In this article, we describe the phenotype of the Pv-Dc2 mice at
the behavioral level and correlate these changes with those found
for GABAA receptor binding sites in specific brain regions. We
also restored the wild-type c2 subunit to some Pv-cell types of Pv-
Dc2 mice such as the cerebellar molecular layer neurons and
reticular thalamus (Pv-Dc2-partial rescue mouse line). This
enabled us to judge which parts of the behavioral phenotype of
Pv-Dc2 mice were likely due to disturbances in other brain regions
beyond the cerebellum and reticular thalamus.
Methods
Animals
Ethics. All procedures for generation and maintenance of
mouse lines were done in accordance with the United Kingdom
Animals (Scientific Procedures) Act 1986 (Home Office Licence
number PPL 60/3562), and had ethical approval from the
Tierschutz Commission of the Regierungspraesidium Karlsruhe,
Germany (project title ‘‘veraenderte Ionenkanaele im Gehirn’’,
granted 30.09.2002). All behavioral animal experiments were
carried out with the permissions (ESLH-2004-01605/Ym-23 and
ESLH-2006-09005/Ym-23) of the State Provincial Government of
Southern Finland. All efforts were made to minimize the number
and suffering of animals.
c2I77lox and Pv-Dc2 mice. As a background line we used
c2I77lox mice [11], in which the GABAA receptor c2 subunit F77
residue is point-mutated to encode I77, causing an inability of the c2
subunit-dependent benzodiazepine binding site to bind the sedative-
hypnotic zolpidem and the b-carboline convulsant 3-carbomethoxy-
4-ethyl-6,7-dimethoxy-b-carboline (DMCM) [33,34]. In other
aspects the c2I77 subunit-containing GABAA receptors function
normally [34]. Pv-Dc2 mice were generated by crossing c2I77lox
mice with PvCre mice as previously described [6].
Pv-Dc2-partial rescue mice. If two different transgenes are
mixed and co-injected into pro-nuclei, they often co-integrate in
the same genomic position (e.g.[35,36]). We exploited this to link
Cre and c2F77GFP transgene expression in Pv cells in the same
mouse line by co-injecting two Pv BAC transgenes: PvCre [9] and
Pvc2F77GFP. To make the Pvc2F77GFP transgene, we followed the
strategy of [4] and [9], who placed eGFP and Cre respectively into
the first coding exon of the Pv gene via bacterial homologous
recombination (Figure 1A). We used BAC clone 450D23 from the
mouse 129SV strain library (Research genetics, Inc., Huntsville,
AL, USA) containing the Pv gene plus $50 kb upstream and
15 kb downstream genomic sequence [4,9].The targeting cassette
consisted of a reading frame of c2L fused at its N-terminus with an
eGFP/9E10 epitope tag (c2F77GFP) [11,37] flanked by stretches of
homologous sequence upstream and downstream of the
translational start of the Pv gene. The 39 recombinogenic arm
(612 bp) was generated previously by PCR with the following
primers: Pv39RA_s (59-GCCTTTGCTGGTGAGCAATGCAC-
39) and Pv39RA_as (59-AAGAGATCACACAGCCGAGTG-
GGT-39), and inserted into the EcoRV site of pBluescript II SK
to generate pBS-39RA [4]. The c2F77GFP reading frame was
inserted into an EcoRI site immediately 59 of the 39
recombinogenic arm in pBS-39RA to generate pBS-c2F77GFP-
39RA. The 59 recombinogenic arm (1.2 kb) containing a SalI site
at the 59 end was generated by PCR with the following primers:
Pv59RA_s (59-CCCCGTCGACCAGGGCTCAGCTAAGGAA-
39), Pv59RA_as (59-CTGCAACTGTTTGAGCGGGCAGAG-
39). To fuse the 59 untranslated region of the Pv gene directly to
the translational start of c2F77GFP, a 280 bp fragment of the 59
coding sequence of c2F77GFP was amplified by PCR using the
following primers: c2GFPs (59-GATGAGTTCGCCAAATAC-
ATGGA-39) and c2GFPas (59-GGTGGTACCGATGAACTT-
CAGG-39). A KpnI site was introduced into the 39 end of the
PCR product during amplification. The 59 recombinogenic arm
was cut with SalI, the 280 bp PCR product of c2F77GFP was cut
with KpnI. The blunt ends of these fragments were joined in a
triple ligation into pBluescript II SK digested with SalI and KpnI
to generate pBS-59RA-59c2F77GFP. The 59RA-59c2F77GFP insert
was released from pBS-59RA-59c2F77GFP by BglII/EcoRI digest
and inserted into pBS-c2F77GFP-39RA digested with BglII and
partially digested with EcoRI to result in pBS-59RA-c2F77GFP-
39RA. The final recombination cassette containing the 59 and 39
recombinogenic arms flanking the c2F77GFP reading frame was
released from pBS-59RA-c2F77GFP-39RA by SalI digest and
inserted into the SalI-digested shuttle vector pSVrecA. The
recombination cassette was integrated into the translational start
of the Pv gene in BAC 450D23 via bacterial homologous
recombination [38]. For pronucleus injection, BAC DNA was
prepared by cesium chloride gradient centrifugation and digested
with NotI to release the BAC insert [4]. The insert was separated
from the vector on a CL4B-Sepharose (GE Healthcare Life
Sciences Ltd, UK, Amersham Place, Buckingshamshire, UK)
column.
For the co-injection of the PvBAC-c2F77GFP with the PvBAC-
Cre transgenes [9], the two isolated BAC inserts were mixed 1:1
prior to injection. The mixture was injected into the pronuclei of
B6D2F2 mouse zygotes at a concentration of 0.7 mg/ml (done by
Dr. F. Zimmermann, University of Heidelberg). Founder mice
were identified by Southern blot analysis of XbaI digested
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Figure 1. Construction of Pv-Dc2-partial rescue mice. (A) Illustration of the PvBAC-Cre and PvBAC-c2F77GFP transgene constructs. Cre
recombinase and c2F77GFP cDNAs respectively were inserted into the start codon located in exon 2 of the Pv gene in BAC 450D23 via bacterial
homologous recombination. XbaI restriction sites and the probe (black bar) used for southern blot analysis of founder mice are indicated. (B)
Southern blot analysis of XbaI-digested genomic DNA of a wild-type (lane 1) and a transgenic (lane 2) animal hybridized with the 59 recombinogenic
arm shows bands at about 4.7 kb (wild-type), 6.2 kb (Cre transgene) and 7.7 kb (c2F77GFP transgene). (C) In situ hybridization autoradiographs show
Behaviour of Mice without Inhibition in Pv-Neurons
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genomic DNA hybridized with the 59 recombinogenic arm. This
probe recognizes a ,4.7 kb wild-type band, a ,6.2 kb band in
mice transgenic for Cre recombinase and a ,7.7 kb band in mice
transgenic for c2F77GFP (see Figure 1B). The same method was
used for genotyping the offspring. Brains of offspring were
analysed by in situ hybridization (see below) with eGFP- and
Cre-specific probes, which pick out the c2F77GFP and Cre
transgenes, respectively (Figure 1). Three lines showed transgene
expression. One line (PC7) was then crossed with c2I77lox mice
[6,11] to generate Pv-Dc2-partial rescue mice.
Neurochemical assays
In situ hybridization. In situ hybridization to adult mouse
brain sections with [35S]-labeled oligonucleotide probes was
performed as described [39]. Images were generated from 10-
week exposures to Kodak Biomax MR X-ray film (Eastman
Kodak, Rochester, NY). To assess non-specific labeling of the
sections, each labeled oligonucleotide was hybridized to brain
sections with a 100-fold excess of unlabeled oligonucleotide.
Oligonucleotide sequences were:
eGFP:
59-ATGCGGTTCACCAGGGTGTCGCCCTCGAACTTCA-
CCTCGGCGCGGGT-39,
Cre recombinase:
59-CTGAACATGTCCATCAGGTTCTTGCGAACCTCAT-
CACTCGTTGCA-39,
Pv:
59-TCTTCAGGCCCACCATCTGGAAGAACTTTTTGTG-
GTCGAAGGAGT-39.
Immunohistochemistry. To confirm the selective
expression of GFP in a subset of PV-containing neurons, Pv-
Dc2-partial rescue mice were deeply anaesthetized with sodium
pentobarbital (100 mg/kg, i.p.) and transcardially perfused in
accordance with the UK Animals (Scientific Procedure) Act 1986
and associated procedures. The initial solution was 0.1 M
phosphate-buffered saline (PBS), followed for 12 min by a
fixative composed of 4% paraformaldehyde and 0.2% picric
acid made up in 0.1 M phosphate buffer (PB, pH 7.2). Brains were
removed, and sectioned in the sagittal plane on a Vibratome.
Double immunofluorescence reactions were performed on free-
floating sections. These were incubated in a blocking solution of
20% normal donkey serum (NDS) diluted in Tris-buffered saline
(TBS, pH 7.4, 0.3% Triton) for 2 h. The sections were then
incubated in the following cocktail of primary antibodies overnight
at 4uC: affinity purified rabbit anti-GFP (1:1000) (Invitrogen;
Catalog Number A-11122), and mouse anti-parvalbumin (1:5000)
(Swant; Catalog Number 235). The following day, the sections
were rinsed thoroughly in TBS and then incubated in a cocktail
containing donkey anti-rabbit Alexa 488 (1:1000) (Invitrogen) and
donkey anti-mouse Cy3 (1:1000) (Jackson ImmunoResearch) for
2 h at room temperature. The sections were rinsed in PB and
mounted in Vectashield (Vector Laboratories, Burlingame, CA).
Sections were examined with a confocal laser-scanning
microscope (LSM710; Zeiss, Oberkochen, Germany) using either
a Plan Apochromatic 636 DIC oil objective (NA1.4). Z-stacks
were used for routine evaluation of the labelling. The images
presented represent a single optical section. These images were
acquired using sequential acquisition of the different channels to
avoid cross-talk between fluorophores, with the pinholes adjusted
to one airy unit for all channels. Images were processed with the
software Zen2008 Light Edition (Zeiss) and exported into Adobe
Photoshop. Only brightness and contrast were adjusted for the
whole frame, and no part of a frame was enhanced or modified in
any way.
Ligand autoradiography. To assess the expression of
wild-type c2 subunits forming high-affinity GABAA receptor
benzodiazepine binding sites from the Pvc2F77GFP transgene in
Pv-Dc2-partial rescue mice, [3H]Ro 15-4513 autoradiography was
performed as described [40]. Fourteen-mm cryostat sections were
obtained from wild-type c2F77 (n = 2), c2I77 (n = 7), Pv-Dc2
(n = 5) and Pv-Dc2-partial rescue (n = 7) mice. Brain sections were
preincubated for 15 min in an ice-water bath in incubation buffer
[50 mM Tris-HCl, 120 mM NaCl (pH 7.4)]. The final incubation
took place with 15 nM [3H]Ro 15-4513 (Perkin Elmer, Boston,
MA, USA) in the incubation buffer in the dark at 4uC for 60 min
in plastic slide mailers. Nonspecific binding was determined with
10 mM Ro 15-1788 (flumazenil; Tocris Biosciences, Ellisville, MO,
USA). After the incubation the sections were washed with ice-cold
incubation buffer for 2660 s, dipped in distilled water and dried in
air flow at room temperature.
t-Butylbicyclophosphoro[35S]thionate ([35S]TBPS) binding to
mouse brain sections was performed as described [41]. Sections
from c2I77 (n = 6), Pv-Dc2 (n = 5) and Pv-Dc2-partial rescue
(n = 6) mice were preincubated 3610 min in an ice-water bath in
50 mM Tris-HCl (pH 7.4) in the presence of 1 mM EDTA (Sigma
Aldrich Chemical Company, St. Louis, MO, USA), which was
then washed out. The final incubation took place with 6 nM
[35S]TBPS (GE Healthcare corp., Piscataway, NJ, USA) in the
incubation buffer (50 mM Tris-HCl, 120 mM NaCl, pH 7.4) at
room temperature for 90 min. Nonspecific binding was deter-
mined with 100 mM picrotoxinin (Sigma). The effects of 2 mM and
1 mM GABA on radioligand binding were investigated. After the
incubation the sections were washed with buffer (10 mM Tris-
HCl, 120 mM NaCl, pH 7.4) for 362 min (for 2 mM GABA) or
3630 min (for 1 mM GABA), dipped in distilled water and dried
in air flow at room temperature.
For [3H]Ro 15-4513 autoradiography, the sections were
exposed to Kodak Biomax MR film for 24 weeks with 3H-
radioactivity standards (GE Healthcare); for [35S]TBPS autoradi-
ography, sections were exposed to the same film type for 6 weeks
with 14C-radioactivity standards (GE Healthcare). Binding densi-
ties in the relevant brain areas were quantified with MCID M5-
imaging software (GE Healthcare) and converted to radioactivity
values (nCi/mg for 3H and nCi/g for 14C) on the basis of the
the expression of Cre (middle panel) and c2F77GFP (right panel) mRNA in Pv-Dc2-partial rescue mice, which is less widespread than native expression
of Pv mRNA (left panel). Cb, cerebellum; col, superior and inferior colliculi; Ctx, cortex; Hi, hippocampus; nRT, reticular nucleus of thalamus. (D)
Overview of GFP and parvalbumin immunoreactivity in the thalamus with magnified views provided by the inserts. D1 shows that GFP labelling is
restricted to the reticular nucleus of the thalamus. D2 shows parvalbumin labelling only in neurons of the reticular nucleus. D3, an overlay of D1 & D2
shows the co-localisation of GFP with parvalbumin confirming the restricted expression of GFP only in parvalbumin-containing neurons in this brain
region. (E) Overview of GFP and parvalbumin immunoreactivity in the cerebellum with magnified views provided by the inserts. E1 shows that GFP
labelling is concentrated in the Purkinje cell and molecular layers of the cerebellar cortex with the insert showing strong immunoreactivity on
Purkinje cell dendrites and molecular layer interneurons (arrowheads) with weaker labeling evident in a Purkinje cell soma (arrow). E2 shows
characteristic parvalbumin labelling restricted to Purkinje cells and molecular layer interneurons (arrowheads). E3, an overlay of E1 & E2 shows the co-
localisation of GFP with parvalbumin confirming the restricted expression of GFP only in parvalbumin-containing neurons in the cerebellum. Scale bar
200 mm, insert 20 mm.
doi:10.1371/journal.pone.0024159.g001
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simultaneously exposed standards. Nonspecific binding was
subtracted from all values.
Behavioral experiments
Animals were bred either in the University of Heidelberg,
Germany, in the University of Aberdeen, UK, or in the Medical
University Vienna, Austria and sent to Helsinki at the age of 4–5
months, after which they were acclimatized to the animal facility
conditions for 7 days before commencing behavioral testing. The
animals were housed (1–5 per cage) in transparent polypropylene
cages (37621615 cm, Tecniplast, Buguggiate, Italy) with standard
rodent pellets (Harlan BV., Horst, Netherlands) and tap water ad
lib. Lights were on from 7 a.m. to 7 p.m., under 12:12 h light:dark
cycles, at 21–23uC and a humidity of 50–60%.
Pv-Dc2 male (n = 16) mice, Pv-Dc2-partial rescue male (n = 16)
and female (n = 20) mice, littermate wild-type c2F77 male (n = 3)
and female (n = 2) and control littermate c2I77 male (n = 31) and
female (n = 16) mice aged 4–10 months (15–45 g) were used.
The SHIRPA observational screen was performed with naı¨ve
mice, after which elevated plus maze, acoustic startle and prepulse
inhibition, Morris water maze, motor coordination, tremor and
nociception testing were carried out. About one week after the last
experiments the animals were strongly sedated with CO2,
decapitated, and brains were collected for further analysis.
SHIRPA test. Basic behavioral and physiological chara-
cterization of phenotype was performed using a modified version
[42] of the primary observational screen described in the SHIRPA
protocol (http://empress.har.mrc.ac.uk/browser/?sop_id = 10_002_
0). The person who observed and recorded the behavior was blind to
the genotype of the animals. The animals were naı¨ve to handling at
the time of SHIRPA testing.
Elevated plus-maze. To investigate the basal anxiety level of
the mice, an elevated plus-maze test was performed. The test was
performed after the primary SHIRPA screen, before any other
tests. The apparatus was made of grey plastic and elevated to
50 cm from the floor level. It consisted of a central platform
(565 cm), from which two open arms (5640 cm with a 0.7 cm
ledge) and two enclosed arms (5640620 cm) extended [43]. The
light intensity was set at 50 lux on the open arms and 20 lux in the
closed arms. The mice were placed individually on the central
platform facing an open arm and allowed free exploration of the
maze for 5 min with their behavior being recorded using a video
tracking system with a CCD video camera above the plus maze
[44]. The position and movements of the center of the animal’s
surface area were analyzed automatically using EthoVision
software (Noldus Information Technology, Wageningen,
Netherlands). The central area was extended to include the first
2 cm of each arm. An arm entry was recorded when the center of
the mouse entered the distal part of the arm. This corresponds to
the definition of an arm entry with all four legs on the arm [43].
The plus-maze was cleaned with a water-moistened paper towel
and dried after each mouse. The mice were returned to their home
cage when all mice from the same cage were tested.
Acoustic startle response and prepulse inhibition. The
acoustic startle response and prepulse inhibition (PPI) were
measured using a two-unit automated startle system (Startle
Reflex System, Med Associates Inc., St. Albans, VT, USA) based
on previously described procedures for mice (modified from
[45,46]). In an illuminated and sound-attenuated chamber, a small
cage (7.5 cm long, 3.5 cm wide and 4.0 cm high) with metal bars
was mounted above a piezoelectric sensor. Movements of the
animal in the cylinder were detected by a piezoelectric sensor,
digitized and analyzed by Startle Reflex System software (version
4.01, Med Associates Inc.). The sensitivities of the two chambers
were calibrated and adjusted to be identical (Platform calibrator,
Med Associates Inc.). Background noise of 65 dB and acoustic
stimuli were delivered through speakers in the ceiling of the
chambers. Mice were acclimated to the cylinders and chambers
for 5 min daily for five days before the experiments. First, acoustic
startle responses to stimuli of different intensities were determined.
The test session began with a 5-min acclimation. Background
noise was on during the acclimation period and throughout the
session. The acclimation period was followed by seven blocks of
trials containing seven stimuli (40 ms) of different intensities (65,
71, 75, 85, 95, 110 and 120 dB) in a pseudorandom order. The
intertrial interval varied between 9–21 s. The test session
contained 49 trials and lasted approximately 20 min.
Following at least a 3-day wash-out after startle testing, PPI was
analyzed. To habituate the mice to the test stimuli, the test session
began with six trials of 110 dB stimuli (40 ms) which were not
included in the analysis. This was followed by 10 blocks of four
trials containing 110 dB startle stimuli alone and combined to a
71 dB prepulse stimulus (20 ms). The prepulse stimulus was also
delivered alone five times during the session. The order of different
type of stimuli was pseudorandom. The interval between prepulse
and startle stimuli was 100 ms and intertrial interval varied
between 9–21 s. The test session contained 51 trials and lasted
approximately 20 min. To investigate whether antipsychotics
could reverse the observed deficits in PPI, the effects of 0.5 mg/
kg haloperidol (20 min before testing) [47] and 4 mg/kg clozapine
(30 min before testing) [46] were tested in Pv-Dc2-partial rescue
mice. To investigate whether psychotomimetics would deteriorate
the deficits further, Pv-Dc2-partial rescue mice were administered
0.15 mg/kg MK-801 (20 min before testing) [48].
The movements of the mouse were sampled for 50 ms before
the first stimulus (null period) and for 200 ms after the first
stimulus. The startle amplitude was defined as the peak amplitude
that occurred during the first 100 ms after the onset of the startle
stimulus. If the movements of the animal produced a clear signal
(differed more than6150 units from zero) during the null period,
the trial was excluded from the results. The exclusion was done by
an experimenter viewing graphs from each trial without knowing
the type of the stimulus and blind to animal genotype. The percent
prepulse inhibition (PPI) was calculated from the formula:
%PPI = [(amplitude of startle pulse alone – amplitude of startle
pulse when preceded by a prepulse)/amplitude of startle pulse
alone]6100.
As an enhanced sensitivity to 0.15 mg/kg MK-801 was
observed in the PPI experiments, behavioral scoring of Pv-Dc2-
partial rescue mice was conducted in a separate experiment. MK-
801 (0.15 mg/kg) or vehicle was administered to Pv-Dc2-partial
rescue and control c2I77 mice and their behavior was observed in
the home cage at 5 min intervals for 20 min and following that at
60, 90, 120 and 180 min after injection. The mice were visually
scored (6) for the presence of any abnormal symptoms (agitation,
jumping, hyperlocomotion, stereotypic behavior, seizures).
Morris water maze. Mice were trained during 4 days (6
trials/day, with a 10-min inter-trial interval) to find a platform
submerged circa 1 cm below the surface of a 120-cm diameter
pool of water. Visual markers were placed on the walls of the
experiment room to facilitate spatial learning. The pool was
divided into 4 equal quadrants. During training the platform was
constantly in the same quadrant of the maze, and the quadrant in
which the mice were placed varied from trial to trial in a
pseudorandom manner. The water temperature was 19–20uC and
the water was opacified with milk powder to prevent the mice from
seeing the platform. Inter-trial interval was circa 10 min and trial
cut-off time 3 min. If the mouse did not find the platform during a
Behaviour of Mice without Inhibition in Pv-Neurons
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trial, it was gently guided onto it. The mice were towel-dried after
each trial and placed on a heater pad (38uC) for 1 min before
returning them to home cage. The escape latency, swimming
velocity and total distance were recorded via Ethovision. The mice
were also monitored from a TV-screen in a separate room to
prevent drowning. One day after training, on day 5, a 1-min probe
trial was performed in which the platform was removed and the
time the mice spent in the platform quadrant as well as the
number of visits to the former platform position and the swimming
velocity were recorded (modified from [49]).
Motor tests. To investigate motor coordination of Pv-Dc2
and Pv-Dc2-partial rescue mice, rotarod tests were performed
[50]. The mice were trained during 6 days (4–6 trials per day) to
stay on a rotating rod (diameter 4 cm, Rotamex 4/8, Columbus
Instruments, Ohio, USA) for 180 s, with the rotation speed being
accelerated from 5 to 20 rpm (Pv-Dc2 mice) or from 5 to 30 rpm
(Pv-Dc2-partial rescue mice). The latency to fall from the rod in
each trial was recorded and a daily average of 4–6 trials was
calculated for each animal.
The mice were also trained to walk along a 100-cm-long
wooden beam (0.8 cm in diameter) back to their home cage [51].
One end of the beam was mounted on a supporter and the other
on the edge of the home cage so that the beam was 84 cm above
the floor. If the mouse did not move within 10 s it was gently
pushed to induce movement. If the mouse slipped or fell it was
helped back onto the beam. The latency to reach the other end of
the beam was recorded. Training for the beam test was conducted
twice a day for 6 days.
To assess pharmacological sensitivity, mice were injected with
zolpidem (1–3 min prior to rotarod testing) or DMCM (both
15 min prior to rotarod testing). In some zolpidem and DMCM
tests a pretreatment of 15 mg/kg flumazenil was used.
Tremor. Mice were habituated to glass holding jars (diameter
10 cm, height 14 cm) for 5 days, 5 min at a time. The tremor
measurement apparatus was developed in-house and consisted of a
piezoelectric weight sensor with three independent measuring
stations. The holding jars were placed on fast scaling cells that
measured weight up to 200 g. The measurement software was
written using VEE Pro 6.0 (Agilent Technologies Inc., Espoo,
Finland). The weight signal was sampled with an AD/convert
(DT9804, Data Translation Inc., Marlboro, MA, USA) with a
sample rate of 200 Hz and stored for further analysis. The tremor
could be seen as fast variation in the weight signal. On the test day,
baseline measurements were performed for 5 min, after which
mice were injected with 15 mg/kg harmaline (Sigma) and tremor
was measured 15 min later for 5 min. The data was analyzed with
a software tool developed in-house, created with MathWorks
MatlabH (MathWorks, Natick, MA, USA). From the total duration
of all recorded tremor amplitude and frequency data, manually
selected time regions were analyzed with a spectrogram function,
to attain 1) the power of all possible frequencies found in the data
at each time point, 2) the dominant frequency at each time point,
which was calculated by finding which frequency had the
maximum power at a given time and 3) dominant frequency
distribution, which was calculated from the mean power of each
frequency over the selected time period.
Pain sensitivity. Mice were acclimatized to the hot plate test
apparatus (Hot Plate Analgesic Meter, Harvard Apparatus,
Edenbridge, UK) for 5 days by placing them on an unheated
hot plate inside a plastic cylinder (20 cm in diameter) daily for
3 min. During the test, the hot plate surface was maintained at
5260.2uC. The latency to react was scored visually when the
mouse rapidly moved or licked its hindpaw or jumped. The cutoff
time was 40 s.
The mice were acclimatized to the tail-flick test procedure and
apparatus (Model-DS20, Ugo Basile, Comerio, Italy) for 7 days by
gently holding them immobile inside a cloth for 3 min. In testing
basal pain sensitivity, the intensity of light was 15 V and the cutoff
time 12 s. On the distal part of the tail, 1 cm area was marked
with a black felt pen and heat was directed to this area. In testing
for DMCM sensitivity, a shorter cut-off time of 8 s was used with
slightly higher light intensity (24 V). Before drug or vehicle
administration, two basal reaction times, 15 min apart, were
determined. The latencies to the tail withdrawal reaction were
analyzed after saline injection and 20 min after DMCM (3 mg/kg)
injection.
Drugs for behavioral experiments. Zolpidem tartrate was
crushed from tablets (StilnoctH, Sanofi-Synthelabo AB, Bromma,
Sweden) and suspended in physiological saline. DMCM (Sigma)
was dissolved in physiological saline acidified with a few drops of
0.1 N HCl (pH.4). Flumazenil (Tocris Biosciences, Ellisville, MO,
USA) was dissolved in Tween 80, which was diluted to 3% with
physiological saline. Haloperidol was diluted from concentrate
(SerenaseH, Orion Pharma, Espoo, Finland) and brought to
concentration with physiological saline. Clozapine was crushed
from tablets (LeponexH, Novartis, Basel, Switzerland) and
suspended in physiological saline. MK-801 (Sigma) was
suspended in Tween 80 and brought to concentration with
physiological saline (final Tween 80 concentration 3%). All
substances were injected i.p. in a volume of 10 ml/kg.
Statistical analyses
The results are given as means 6 SEM, unless otherwise stated.
Statistical tests were performed with SPSS Software (SPSS 12.0.1,
SPSS Inc., Chicago, Illinois, USA) or GraphPad Prism software
(Prism 5.0, GraphPad Software Inc., California, USA). Treatment
groups and mouse lines were compared with either Student’s t-test,
Mann-Whitney U-test, Wilcoxon signed rank test, repeated
measures ANOVA or one-way ANOVA followed by Newman-
Keuls post hoc-test or Dunnett’s test. In all statistical tests the level of
significance was set at p,0.05.
Results
Mouse line description and general characterization
We used three strains of mice: the c2I77lox line [11,34], mice
with selected disruption of the c2 gene in Pv cells (Pv-Dc2; [6]),
and a novel strain (Pv-Dc2-partial rescue), where the c2 subunit is
expressed in some Pv cell types but not others (Figure 1).
The origin of the Pv-Dc2-partial rescue strain was accidental. In
a similar way to how we made Purkinje cells selectively sensitive to
zolpidem [11,52], we had planned to make a complete swap of c2
subunits in Pv cells, such that Pv cells would selectively express
zolpidem-sensitive abc2F77GFP GABAA receptors and all other
neurons in the brain would express the zolpidem-insensitive
abc2I77 version. This swap would require deletion of the c2I77
gene in Pv cells with Cre and simultaneous expression of c2F77GFP
in the same Pv cells. To streamline the mouse breeding, we chose
to co-integrate the PvCre and Pvc2F77GFP BAC transgenes. In
these lines, we examined by in situ hybridization the neuronal
expression of the BAC transgenes to see if they followed the
expression of the endogenous Pv gene (Figure 1). Three founders
(PC2, PC7, PC10) generated offspring with transgene expression,
at the level of X-ray film analysis, that resembled the Pv gene
expression ‘‘signature’’ of reticular thalamic and cerebellar
molecular layer/Purkinje cell layer expression (compare the Cre,
GFP and native Pv expression patterns seen by in situ
hybridization; Figure 1C). The expression of Cre/c2F77GFP
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transgenes in other brain areas of Pv-Dc2-partial rescue mice was
negligible, except for a small amount in the superior and inferior
colliculi (Figure 1C). Thus, the Cre/c2F77GFP transgene pattern
did not fully resemble the native Pv gene expression pattern.
Nevertheless, we took the line (PC7) with the strongest Cre and
c2F77GFP transgene expression and crossed this line into the
c2I77lox line to generate, ultimately, the Pv-Dc2-partial rescue
mice: in the Pv-Dc2-partial rescue mice, the c2 gene is disrupted in
most Pv-cell types, but c2F77GFP expression is present for example
in the molecular layer cells of cerebellar cortex (Purkinje, stellate
and basket cells) and the reticular thalamic neurons (Figure 1C-E).
We used autoradiography of [3H]Ro 15-4513 binding to c2
subunit-containing GABAA receptor benzodiazepine sites [40] to
confirm the pattern and amount of c2F77GFP transgene expression
in Pv-Dc2-partial rescue mice. Ro 15-4513 binds with high affinity
to c2F77 GABAA receptors, but not to those with a c2I77
mutation [34,53,54]. Binding in the cortex, thalamus, hippocam-
pus, inferior colliculus and cerebellar granule cell layer of Pv-Dc2-
partial rescue mice was minimal compared with wild-type c2F77
mice (Figure 2A for images), the small amount of residual binding
being most likely due to GABAA receptors with c1 or c3 subunits
[55]. However, the [3H]Ro 15-4513 binding levels in Pv-Dc2-
partial rescue mice were approximately 55% of wild-type binding
in the thalamic reticular nucleus and 16% in the molecular layer of
cerebellum (Figure 2A–B). This matches the qualitative in situ
hybridization data obtained with GFP probes (Figure 1C) and
indicates rescue of pharmacologically active wild-type receptors in
those brain regions.
Altered GABA sensitivity and appearance of ab-type
GABAA receptors in many brain areas of Pv-Dc2 mice
Sections of Pv-Dc2 (n = 5), Pv-Dc2-partial rescue (n = 5) and
control c2I77 (n = 5) mouse brain and spinal cord were co-
incubated with the GABAA receptor ion channel ligand
[35S]TBPS to visualize the overall density and GABA sensitivity
of GABAA receptors. The basal binding all over the brain and
spinal cord was similar in all mouse lines, except for the midbrain
and pons, in which several regions of the transgenic mice showed
increased basal [35S]TBPS binding (Figure 3 and Table S1).
However, the basal binding to cerebral cortex, striatum,
hippocampus and cerebellum was not altered in the transgenic
mice. The effect of 2 mM GABA, which is close to the GABA EC50
value, on [35S]TBPS binding was studied to evaluate the sensitivity
of receptors, with the aim to localize ab GABAA receptors by
reduced binding (more inhibition of binding by GABA) as c2
subunit-deficient ab receptors are known to be more sensitive to
micromolar concentrations of GABA than abc2 receptors [24].
Changes in the effects to 2 mM GABA were detected widely in the
midbrain and pontine structures, such as the substantia nigra pars
reticulata, periaquaductal gray area, raphe nuclei and vestibular
and olivary nuclei, in which both Pv-Dc2 and Pv-Dc2-partial
rescue mice had larger percent inhibition of the binding than the
control mice (Figure 3A and Table S1). Peculiarly, in some
regions, such as the medial division of central amygdala of the Pv-
Dc2 mice, but not Pv-Dc2-partial rescue mice, the opposite
change was observed, i.e. 2 mM GABA affected the [35S]TBPS
binding less in these mice than controls (Figure 3B, Table S1), the
reason for which remains to be studied.
The effect of 1 mM GABA on [35S]TBPS binding was studied
to further investigate the composition of the GABAA receptors of
Pv-Dc2 and Pv-Dc2-partial rescue mice. Changes in the amount of
‘‘GABA-insensitive binding’’, i.e. [35S]TBPS binding which
cannot be displaced by even high saturating concentrations of
GABA, may imply changes in the ratio of abc2 receptors to ab
Figure 2. Autoradiographic distribution of brain GABAA
receptor benzodiazepine-site labeling in Pv-Dc2 mouse mod-
els. (A) Representative autoradiographic images of high-affinity [3H]Ro
15-4513 binding to brain sections from wild-type c2F77, control c2I77,
Pv-Dc2 and Pv-Dc2-partial rescue mice. Ctx, cortex; CPu, caudate-
putamen; Th, thalamus; nRT, reticular nucleus of thalamus; Hi,
hippocampus; IC, inferior colliculus; Mol, cerebellar molecular layer.
Inserts depict the nRT in more detail. (B) Quantitative results of [3H]Ro
15-4513 binding to the reticular nucleus of thalamus and cerebellar
molecular layer of wild-type c2F77 (n = 2), control c2I77 (n = 7), Pv-Dc2
(n = 5) and Pv-Dc2-partial rescue (n = 7) mice, indicating partial rescue of
the binding sites in Pv-Dc2-partial rescue mice. Data are presented as
means 6 SEM.
doi:10.1371/journal.pone.0024159.g002
Behaviour of Mice without Inhibition in Pv-Neurons
PLoS ONE | www.plosone.org 7 September 2011 | Volume 6 | Issue 9 | e24159
receptors [44,56,57]. This binding component was increased
several fold in midbrain and pons of Pv-Dc2 and Pv-Dc2-partial
rescue mice, and also widely in the forebrain areas of Pv-Dc2-
partial rescue mice (Figure 3A, Table S1). In many, but not all, of
these areas, there were opposite changes from the control brains in
the effects of 2 mM GABA and 1 mM GABA, which indicates that
there was an increased population of GABAA receptors without
the c2 subunit.
A more thorough concentration-response curve for GABA was
established for the spinal cord sections from c2I77, Pv-Dc2 and
Pv-Dc2-partial rescue mice (Figure 3C). In the spinal cord of c2I77
mice so-called ‘‘low-dose-hook effect’’ [58] was observed with
GABA concentrations ranging from 0.3 to 3 mM, consistent with
the selective non-equilibrium binding properties of a3 subunit-
containing GABAA receptors [59]. In the spinal cords of Pv-Dc2
and Pv-Dc2-partial rescue mice this effect of low GABA
concentrations was attenuated. However, like in many midbrain
and forebrain regions (Figure 3), the GABA-insensitive binding,
determined in the presence of 1 mM GABA, remained higher in
the Pv-Dc2 and Pv-Dc2-partial rescue mice than in the control
mice (Figure 3C, Table S1).
Characterization of the mice at the behavioral level
An observational screen was performed on Pv-Dc2 (n = 15), Pv-
Dc2-partial rescue (n = 22) and c2I77 control mice (n = 21)
(Table 1). c2I77 mice were previously found to be phenotypically
similar to C57BL/6J and littermate control c2F77 mice [34]. The
Pv-Dc2 and Pv-Dc2-partial rescue mice showed no obvious
behavioral alterations during the first postnatal weeks when
compared with control c2I77 mice (data not shown). However, as
Cre started to be expressed from the Pv gene promoter during the
second to third postnatal week [9] and no new c2 protein was
synthesized, Pv-Dc2 and Pv-Dc2-partial rescue mice began to
show various phenotypical changes (see below), such that they
were immediately recognizable from control mice. However,
neither the Pv-Dc2 nor Pv-Dc2-partial rescue mice had an
Figure 3. Characterization of brain regional GABAA receptor ion channel binding sites and their GABA sensitivities in Pv-Dc2 and
control c2I77 mouse lines. (A) Coronal autoradiographic images of [35S]TBPS binding to control c2I77, Pv-Dc2 and Pv-Dc2-partial rescue mouse
brain sections in the presence and absence of 2 mM and 1 mM GABA. The images for basal binding and the effects of 2 mM GABA were scanned with
optimal scanning settings (similar for both conditions and for all mouse lines), whereas the images for the effects of 1 mM GABA were contrast
enhanced for maximum clarity. Ctx, cortex; Amy, amygdala; Hi, hippocampus; Th, thalamus; SNc, substantia nigra pars compacta, PAG, periaqueductal
gray area; Gr, cerebellar granule cell layer;Mol, cerebellar molecular layer. Section distances from bregma: forebrain21.7, midbrain23.16, cerebellum
25.68. (B) Detailed coronal images of [35S]TBPS binding to the amygdala regions from control c2I77, Pv-Dc2 and Pv-Dc2-partial rescue mice (bregma
21.46), showing larger proportional reduction of binding by 2 mM GABA in the control and Pv-Dc2-partial rescue mice than in Pv-Dc2 mice. See, for
quantitative results in Table S1). CeM, medial division of central amygdaloid nucleus. (C) Images of [35S]TBPS binding to control c2I77, Pv-Dc2 and Pv-
Dc2-partial rescue mouse spinal cord, demonstrating the loss of increase in binding by 1 mM GABA in the mutant as compared with the control c2I77
mice. Also graphs presenting quantitative results of [35S]TBPS binding in spinal cord sections from control c2I77 (n = 6), Pv-Dc2 (n = 5) and Pv-Dc2-
partial rescue (n = 6) mice in the presence and absence of 0.3 mM21 mM GABA are shown. The data are means 6 SEM. * p,0.05, ** p,0.01 for the
difference of the pharmacological effect in c2I77 mice compared with baseline (repeated measures ANOVA and Newman-Keuls post hoc test).
## p,0.01 for the difference of the pharmacological effect compared with baseline in Pv-Dc2 and Pv-Dc2-partial rescue mice. x p,0.05, xx p,0.01,
xxx p,0.001 for the difference between c2I77 and Pv-mouse lines.
doi:10.1371/journal.pone.0024159.g003
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increased mortality relative to control mice by at least ca. one year
of age (data not shown).
The adult male Pv-Dc2 mice were small (20.663 g vs.
25.963 g for c2I77 mice, Student’s t-test p,0.001), dragged their
tail and had a clearly visible walking deficit (flattened pelvic
elevation, low belly, wide step, hind legs wide apart), but they
nevertheless moved normally and actively in home cages. They
also had light, intermittent tremor and abnormal trunk curl when
lifted by the tail. Their increase in body weight during 6 months
(from 2 to 8 months of age) was smaller than in c2I77 control
mice, and their food intake per day was also smaller (p,0.05) at
the age of 6 months. The quality of body fur was abnormal
(greasy, matted) compared with controls, possibly due to deficient
grooming. The phenotype of Pv-Dc2-partial rescue mice was
similar in many respects to that of Pv-Dc2 mice (Table 1), but their
gait, pelvic elevation and fur quality were normal unlike in Pv-Dc2
mice. Despite a consistently lower body weight (19.861 g vs.
23.363 g for c2I77 mice, p,0.01) and a slower increase in body
weight from 2 to 8 months of age compared with controls
(p,0.05), their food intake at 6 months was similar to control
mice.
Specific behavioral investigations of the Pv-Dc2 and Pv-Dc2-
partial rescue mice are given below.
Decreased anxiety-like behavior in Pv-Dc2 and Pv-Dc2-
partial rescue mice
Pv-Dc2 (n = 7) and c2I77 (n = 8) mice and Pv-Dc2-partial rescue
(n = 11) with wild-type c2F77 (n = 5, littermates of c2I77 mice) and
c2I77 (n = 6) control mice were tested in the elevated plus-maze
apparatus to evaluate their basal level of anxiety. Pv-Dc2 mice
entered the open arms of the maze more frequently (p,0.05,
Student’s t-test) and spent more time in the open arms (p,0.05)
than control mice (Figure 4A). Pv-Dc2-partial rescue mice also
entered the open arms of the maze more frequently (p,0.05) and
spent more time in the open arms (p,0.05) than control mice
(Figure 4B). However, the overall motor activity of Pv-Dc2-partial
rescue mice was higher than that of the control mice (p,0.001;
Figure 4B).
Table 1. Results of the SHIRPA screen on Pv-Dc2 and Pv-Dc2-partial rescue mice compared with control c2I77 mice.
Changes compared with control c2I77 mice
Parameter measured Pv-Dc2 mice Pv-Dc2-partial rescue mice
body position 0 0
spontaneous activity 2** +***
respiratory rate 0 0
tremor +*** +***
urination 0 0
defecation 0 2*
locomotor activity 0 +***
startle +** +***
gait 2* 0
pelvic elevation 2** 0
tail elevation 2*** 0
touch escape 0 0
trunk curl +*** +*
limb grasping nm +*
visual placing 0 0
grip strength 0 0
pinna reflex, cornea reflex 0 0
toe pinch 2* 0
wire manoeuver 2* 2***
skin color 0 0
provoked biting 0 2**
righting reflex 2* 2***
contact righting reflex 0 0
negative geotaxis 0 0
aggression 0 2*
body temperature 0 0
body weight 2*** 2**
2=decrease, += increase, 0 = no change, nm=not measured.
*p,0.05,
**p,0.01,
***p,0.001 for the significance of the difference between Pv-Dc2 or Pv-Dc2-partial rescue and control c2I77 mice (Mann-Whitney U-test, Wilcoxon signed rank test or
Student’s t-test). n = 15–22 per line.
doi:10.1371/journal.pone.0024159.t001
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Increased acoustic startle in Pv-Dc2-partial rescue mice;
decreased prepulse inhibition in both Pv-Dc2 and Pv-
Dc2-partial rescue mice
The increase in acoustic startle reflex of Pv-Dc2 and Pv-Dc2-
partial rescue mice noted in the SHIRPA screen (Table 1) was
investigated further in acoustic startle chambers. Pv-Dc2 (n = 7)
mice had a trend towards increased amplitudes of startle reflex
(Figure 5A) and the Pv-Dc2-partial rescue mice (n = 12) had
significantly increased startle reflex at sound stimulus intensities
from 75 to 120 dB compared with control c2I77 mice (n = 15)
(sound intensity6line interaction F1,174 = 2.72, p,0.05, repeated
measures two-way ANOVA; Figure 5A). Different values for
control c2I77 mice in these two separate tests are due to
adjustments in detection sensitivity.
PPI of the acoustic startle reflex of both Pv-Dc2 mice (p,0.05,
Student’s t-test) and Pv-Dc2-partial rescue mice (p,0.01) was
decreased compared with that of c2I77 mice (Figure 5B). Acute
‘‘antipsychotic treatment’’ (haloperidol 0.5 mg/kg or clozapine
4 mg/kg) did not restore the PPI of Pv-Dc2-partial rescue mice to
a normal level (Figure 5C; not studied in Pv-Dc2 mice), nor did
acute administration of a psychotomimetic N-methyl-D-aspartate
receptor antagonist MK-801 (0.15 mg/kg) further deteriorate it,
though MK-801 reduced %PPI in c2I77 control mice (Figure 5C).
In Pv-Dc2-partial rescue mice MK-801 (0.15 mg/kg) produced
an agitation syndrome lasting for over 120 min but produced no
overt symptoms in control c2I77 mice. Pv-Dc2-partial rescue and
c2I77 mice were scored visually for the presence or absence of
agitation symptoms (jumping, hyperlocomotion, stereotypic be-
havior, seizures) for 3 h after the MK-801 injection in home cages
(Figure 5D).
Impaired spatial learning in Pv-Dc2 mice
Pv-Dc2, Pv-Dc2-partial rescue and c2I77 control mice were
trained during 4 days to find a submerged platform in a pool of
water. The spatial learning of both Pv mouse lines was impaired as
can be seen from longer latencies to find the platform during
training (Figure 6A), but the learning of Pv-Dc2-partial rescue
mice appears less severely compromised than that of Pv-Dc2 mice.
During the probe trial, the platform was removed and visits by
the mouse to the former platform quadrant as well as the time
spent in different quadrants were recorded. Pv-Dc2 mice had
fewer platform quadrant visits (p,0.05, Student’s t-test)
(Figure 6B) and spent less time spent in the platform quadrant,
compared to their c2I77 control mice (p,0.05) (Figure 6C). They
also spent more time in the quadrant opposite the platform
quadrant (p,0.05). Pv-Dc2-partial rescue mice had a similar
number of platform quadrant visits (Figure 6B) and spent a
similar amount of time in the platform quadrant as their c2I77
control mice (Figure 6C). The swimming velocities during the
whole one-min probe trial were similar in all mouse lines
(Figure 6D), so the longer latencies by the Pv-lines to find the
platform are more likely due to learning/memory deficits than to
motor disturbances.
Impaired motor performance and learning
To investigate the motor capability of Pv-Dc2 (n = 7) and Pv-
Dc2-partial rescue (n = 9) mice, their rotarod performance was
measured. Pv-Dc2 mice learned the rotarod task more slowly than
c2I77 (n = 8) control mice, as demonstrated by shorter latencies to
fall from the rod, even in an easy, 5 to 20 rpm acceleration task
(Figure 7A). There was a genotype difference between Pv-Dc2 and
c2I77 control mice during training (F1,89 = 5.39, p,0.05, repeated
measures two-way ANOVA), being significant on days 1 and 2
(p,0.05, Student’s t-test). The motor learning of Pv-Dc2 mice was
also impaired on the walking beam during the 6-day training
period (genotype effect: F1,89 = 6.32, p,0.05; Figure 7B). There
was a significant difference between lines on days 1 and 6
(p,0.05).
Generally, the Pv-Dc2-partial rescue mice had less impairment
than the Pv-Dc2 mice, and they could be trained to perform a
more difficult task with a rotating rod speed accelerating from 5 to
30 rpm. There was nevertheless a genotype effect (F1,95 = 8.95,
p,0.001, repeated measures two-way ANOVA; Figure 7A), which
was significant on day 1 (p,0.01, Student’s t-test) and day 2
(p,0.05). The performance of Pv-Dc2-partial rescue mice on the
walking beam was almost normal (Figure 7B), but there was still a
genotype effect (F1,95 = 6.89, p,0.05), with the beam traversing
time being significantly longer on day 3 when compared with
c2I77 mice (n = 9; p,0.001).
Figure 4. Comparison of the mouse lines for anxiety-related
behaviors in elevated plus-maze test. (A) Basal anxiety-related
behaviors of Pv-Dc2 mice (n = 7) and control littermate c2I77 mice
(n = 8) in the elevated plus-maze test. (B) Basal anxiety-related behavior
level of Pv-Dc2-partial rescue mice (n = 11), wild type c2F77 (n = 5) and
control littermate c2I77 mice (n = 6). Data from wild-type and c2I77
mice were pooled, since there were no significant differences between
them. x p,0.05, xxx p,0.001 for the difference between the mouse lines
(Student’s t-test). Data are presented as means 6 SEM.
doi:10.1371/journal.pone.0024159.g004
Behaviour of Mice without Inhibition in Pv-Neurons
PLoS ONE | www.plosone.org 10 September 2011 | Volume 6 | Issue 9 | e24159
Altered sensitivity of motor performance to zolpidem
and DMCM
After establishing a stable level of rotarod performance,
pharmacological sensitivities of Pv-Dc2 and Pv-Dc2-partial rescue
mice to GABAA receptor modulators were investigated. The mice
were administered zolpidem (cumulative 20+20 mg/kg) or
DMCM (3 mg/kg) and tested 1–15 min later for the latency to
fall down from the rotarod.
The motor-impairing effects of 20+20 mg/kg zolpidem were
increased in Pv-Dc2 mice (genotype effect: F1,42 = 9.610, p,0.001,
repeated measures two-way ANOVA, data not shown). The effects
of a single 20 mg/kg dose of zolpidem in Pv-Dc2 mice could not
be reversed by pretreatment with 15 mg/kg flumazenil
(Figure 7C). The falling latency of Pv-Dc2-partial rescue mice
did not differ from control mice after zolpidem (data not shown).
DMCM (3 mg/kg) had a motor-impairing effect in Pv-Dc2-
partial rescue mice (Figure 7C; F1,30 = 14.62, p,0.001), but not in
Pv-Dc2 mice (data not shown) nor in c2I77 control mice.
Flumazenil pretreatment (15 mg/kg) significantly reversed the
effect of DMCM in Pv-Dc2-partial rescue mice (Figure 7C).
Importantly, DMCM (3 mg/kg) produced a marked change in the
body posture, decreasing pelvic elevation and flattening the body
and tail onto the floor, without producing apparent sedation.
Unusual harmaline-induced tremor in Pv-Dc2 and Pv-
Dc2-partial rescue mice
The Pv-Dc2 (n = 7) and Pv-Dc2-partial rescue (n = 9) mice had a
mild visible tremor in SHIRPA screening (Table 1). These mice
and c2I77 control mice (n = 7+8) were further tested with a
piezoelectric weight sensor. However, the tremor at baseline
conditions was too slight to be detected with the apparatus, and
therefore, we provoked tremor with the b-carboline alkaloid
harmaline (e.g. [60,61]). When administered 15 mg/kg harmaline,
c2I77 mice developed a constant tremor of 12 Hz, with a mean
amplitude of 5.861.5 tremor units. Although Pv-Dc2 and Pv-Dc2-
partial rescue mice also developed harmaline-tremor, it was
variable in frequency (8–28 Hz) and episodic (1466 episodes
during 300 s in Pv-Dc2 mice; 1667 episodes in Pv-Dc2-partial
rescue mice). The amplitude at the dominant frequency was
Figure 5. Assessment of sensorimotor coordination in Pv-
mouse lines using tests for startle response and prepulse
inhibition of startle. (A) Acoustic startle reflex reaction curves of Pv-
Dc2 and Pv-Dc2-partial rescue mice. Pulse intensity was raised from 65
to 120 dB. Data for Pv-Dc2 (n = 7), Pv-Dc2-partial rescue (n = 15) and
control littermate c2I77 mice (n = 8 for Pv-Dc2 mice and n=15 for Pv-
Dc2-partial rescue mice) are presented as means 6 SEM. x p,0.05,
xx p,0.01, xxx p,0.001 for the difference between Pv-Dc2-partial rescue
and control c2I77 lines (repeated measures ANOVA and Newman-Keuls
post hoc test). (B) Prepulse inhibition (PPI) of the acoustic startle reflex
in Pv-Dc2 and Pv-Dc2-partial rescue mice. Data for Pv-Dc2 (n = 7), Pv-
Dc2-partial rescue (n = 15) and control littermate c2I77 mice (n = 8 for
Pv-Dc2 mice and n=15 for Pv-Dc2-partial rescue mice) are presented as
means 6 SEM. x p,0.05, xx p,0.01 for the difference between Pv-Dc2
or Pv-Dc2-partial rescue line and c2I77 line (Student’s t-test). (C) The
effects of 0.5 mg/kg haloperidol, 4 mg/kg clozapine and 0.15 mg/kg
MK-801 on the PPI of Pv-Dc2-partial rescue mice. Data for Pv-Dc2-
partial rescue (n = 12) and control littermate c2I77 mice (n = 15) are
presented as means 6 SEM. x p,0.05, xx p,0.01, xxx p,0.001 for the
difference between the mouse lines (two-way ANOVA and Newman-
Keuls post hoc test). * p,0.05 for the difference between the drug and
vehicle in c2I77 mice. (D) Average symptom score of agitation
syndrome in Pv-Dc2-partial rescue (n = 12) and control littermate
c2I77 mice (n = 15) during 3 h after 0.15 mg/kg MK-801 administration.
Mice were scored visually for the presence or absence of jumping,
hyperlocomotion, stereotypic behavior and seizures.
doi:10.1371/journal.pone.0024159.g005
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1.860.6 tremor units in Pv-Dc2 mice and 3.162.5 tremor units in
Pv-Dc2-partial rescue mice.
Decreased thermal pain reactivity and increased
analgesic effect of DMCM
Both Pv-Dc2 (n = 5) and Pv-Dc2-partial rescue (n = 11) mice
had a significantly (p,0.001, Student’s t-test) increased reaction
latency to hot plate-induced thermal pain sensation compared
with control c2I77 mice (n = 9+8; Figure 8A).
In the tail flick test, both Pv-lines had similar latencies as the
control mice (Figure 8A), indicating that their spinal pain reflexes
were normal. However, when the Pv-Dc2 and Pv-Dc2-partial
rescue mice were tested for tail flick responses after DMCM
(3 mg/kg) we found evidence for an analgesic effect (Figure 8B). In
Pv-Dc2 mice, DMCM slightly lengthened the latency for tail flick
compared with c2I77 control mice (p,0.05, two-way ANOVA
and Newman-Keuls post hoc-test), also when compared with the
vehicle values (p,0.01). In the experiment with Pv-Dc2-partial
rescue mice, there was a hyperalgesic effect after vehicle treatment
in all animals. DMCM produced a full analgesic response (no tail
flick until the 8 s cut-off) in a subgroup of Pv-Dc2-partial rescue
mice, while two-thirds of them were insensitive to it. Using another
group (n = 7) of Pv-Dc2-partial rescue mice, we confirmed that
about one half (n = 4) of the animals did not react to a noxious
thermal stimulus within the cut-off time after receiving DMCM
(6 mg/kg), while the insensitive mice had unchanged latencies
(data not shown).
Discussion
We studied mice in which fast synaptic inhibition onto Pv-
neurons has been abolished [6]. Pv-Dc2 and Pv-Dc2-partial rescue
mice had alterations in many behavioral modalities, including a
decreased level of anxiety-like behavior, impaired motor coordi-
nation, altered expression of tremor, a heightened acoustic startle
reflex and decreased prepulse inhibition of acoustic startle, in
addition to changes in pharmacological sensitivity to GABAergic
substances and the N-methyl-D-aspartate receptor antagonist
MK-801. We could also map alterations of GABAA receptor
properties in a number of brain regions (especially subcortical,
brainstem and spinal regions) of the Pv-Dc2 and Pv-Dc2-partial
rescue mice. Given the wide distribution of Pv cells in the CNS,
such a range of behavioral phenotypes was perhaps expected, even
though the disruption was not lethal.
There were several physical alterations that allowed both Pv-
Dc2 and Pv-Dc2-partial rescue mice to be visually identified, but
the most prominent features were reduced food intake and low
body weight. Decreases in GABAergic tone in hypothalamic
regions important for the control of feeding [62] lead to anorexia
and starvation in mice [63]; and conversely GABAergic agonists,
such as benzodiazepines, promote feeding [64]. Our findings
suggest that on a population of hypothalamic Pv-neurons, the lack
of fast synaptic inhibition may, directly or indirectly, produce the
reduced food intake and lower body weight characteristic of Pv-
Dc2 and Pv-Dc2-partial rescue mice.
Figure 6. Spatial learning and memory in Pv-Dc2 mouse
models. (A) Morris water maze training of Pv-Dc2, Pv-Dc2-partial
rescue and c2I77 mice. Mice were trained during four days to find a
submerged platform in a pool of water. Latency to reach the platform
was recorded. Data are presented as daily averages 6 SEM. xxx p,0.001
for the difference between Pv and c2I77 mice (one-way ANOVA and
Newman-Keuls post hoc test). (B) The number of visits to the former
platform position during the probe trial. x p,0.05 for the difference
between Pv-Dc2 and c2I77 mouse lines, Student’s t-test. (C) Time spent
in the four quadrants during the probe trial. x p,0.05 for the difference
between Pv-Dc2 and c2I77 mouse lines, Student’s t-test. (D) Swimming
velocity of Pv-Dc2, Pv-Dc2-partial rescue and c2I77 mice in the probe
trial.
doi:10.1371/journal.pone.0024159.g006
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Motor deficits
The motor deficits of Pv-Dc2 mice could be rescued to some
extent by expression of the c2 subunit in a subset of Pv-cells
(Purkinje/stellate/basket cells in the cerebellum and neurons of the
reticular thalamic nucleus; Figures 1 and 2). The haplo-insufficiency
phenotypes found with heterozygote c2 total knockout mice [27,29]
Figure 7. Motor performance and motor pharmacological
sensitivity of Pv-Dc2, Pv-Dc2-partial rescue and control litter-
mate c2I77 mice. (A) Motor training of Pv-Dc2 (n = 7), Pv-Dc2-partial
rescue (n = 9) and control littermate c2I77 mice (n = 8 for Pv-Dc2 mice
and n=9 for Pv-Dc2-partial rescue mice). Mice were trained during 6
days to stay for 180 s on a rotating rod accelerated from 5 to 20 rpm for
Pv-Dc2 mice and from 5 to 30 rpm for Pv-Dc2-partial rescue mice.
Latency to fall from the rod was recorded. (B) The mice were also
trained to traverse a 1-m wooden beam (diameter 0.8 cm). Time to
traverse the beam was recorded. Data are presented as daily averages
6 SEM. x p,0.05, xx p,0.01, xxx p,0.001 for the difference in the
corresponding latencies or times to traverse between the mouse lines.
(C) The effect of 20 mg/kg zolpidem in Pv-Dc2 mice on the rotarod;
pretreatment with 15 mg/kg flumazenil. The effect of 3 mg/kg DMCM
in Pv-Dc2-partial rescue mice; pretreatment with 15 mg/kg flumazenil.
xx p,0.01, xxx p,0.001 for the difference between the mouse lines;
* p,0.05, ** p,0.01, *** p,0.001 for the difference between zolpidem
and saline or DMCM and saline; ## p,0.01 for the difference between
vehicle and flumazenil in DMCM-treated mice (repeated measures
ANOVA and Newman-Keuls post hoc test).
doi:10.1371/journal.pone.0024159.g007
Figure 8. Nociceptive responses of the Pv-Dc2 mouse models.
(A) Basal thermal pain reactivity of Pv-Dc2 and Pv-Dc2-partial rescue
mice in hot plate (HP) and tail flick (TF) tests. Data for Pv-Dc2 (n = 5), Pv-
Dc2-partial rescue (n = 11) and control littermate c2I77 mice (n = 9 for
Pv-Dc2 mice and n= 8 for Pv-Dc2-partial rescue mice) are presented as
means 6 SEM. ### p,0.001 for the difference between the mouse
lines (Student’s t-test). (B) The effect of 3 mg/kg DMCM on thermal pain
in the tail flick test. ## p,0.01 for the difference compared with basal
value (two-way repeated measures ANOVA and Newman-Keuls post hoc
test). ** p,0.01, *** p,0.001 for the difference compared with vehicle
injection. xxx p,0.001 for the difference between the mouse lines.
doi:10.1371/journal.pone.0024159.g008
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indicates that there is little, if any, spare c2 subunit capacity; because
the c2 re-expression in the cerebellum and reticular thalamus of Pv-
Dc2-partial rescue mice was still substantially below wild-type levels
(as measured by [3H]Ro 154513 binding, Figure 2), this probably
accounts for some of the residual motor phenotype. Furthermore,
Pv-positive interneurons at the level of spinal cord neuronal
networks are involved in coordinating motor patterns [65,66],
and the spinal cord had deficient GABAA receptors in both Pv-Dc2
and Pv-Dc2-partial rescue mice (Figure 3C). Reduced fast inhibition
onto these interneurons may have directly impaired motor function
of the Pv mouse lines.
Surprisingly, the motor deficits in Pv-Dc2 mice were also
aggravated by administration of a high dose of the benzodiazepine
agonist zolpidem. As the background c2I77 line is globally
insensitive to conventional zolpidem doses [11,33,34], and Pv-Dc2
mice are missing the c2 subunit from Pv-neurons, another
mechanism is needed to explain this sensitivity. We have
previously discovered that the c2I77 line is sensitive to high (40–
60 mg/kg) zolpidem doses [55], possibly via inhibition of neuronal
Ca2+ channels [67,68]. No zolpidem effect was observed in control
c2I77 mice in the present study, probably because the 5 to 20 rpm
task was excessively easy for them to perform. It is also important
to note that the impairment caused by zolpidem in Pv-Dc2 mice
could not be reversed by flumazenil (Ro 15-1788) pretreatment,
which points to an action through a non-abc2 binding site or a
non-GABAA receptor mechanism.
Compared with Pv-Dc2 mice, it is likely that in Pv-Dc2-partial
rescue mice the basal activity of Pv-neurons is partially normalized
due to the presence of fast synaptic inhibition on the reticular
thalamic neurons and some cerebellar cells. This could explain the
differences in pharmacological sensitivity of motor performance
observed between Pv-Dc2 and Pv-Dc2-partial rescue mice.
Whereas DMCM had no motor-impairing effect in Pv-Dc2 mice,
it caused a robust decrease in the latency to fall from the rotarod in
Pv-Dc2-partial rescue mice, which could be significantly reversed
by the benzodiazepine antagonist flumazenil pretreatment, thus
showing that the effect was due to abc2-type receptors. In wild-
type abc2F77 receptors, DMCM is an inverse agonist, decreasing
the effects of GABA via the benzodiazepine binding site. We
hypothezise that DMCM decreases the effects of the inhibitory
inputs onto c2F77GFP-expressing Pv cells and thus increases the
inhibitory load towards the non-Pv cells which contain insensitive
c2I77 GABAA receptors leading to motor impairment. The lack of
zolpidem effect in Pv-Dc2-partial rescue mice was unexpected,
since the presence of wild-type c2F77 subunits in the cerebellum
should lead to some rescue of zolpidem as well as DMCM
sensitivity (cf. [11]). However, in the cerebellar Purkinje cell c2F77
rescue mice different pharmacology of motor performance was
observed as zolpidem impaired the rotarod performance [11].
This indicates that the cerebellar cortical output is delicately
balanced and can be differentially modulated by systemic
activators and inhibitors.
Based on the basal behavioral dissimilarities between Pv-Dc2
and Pv-Dc2-partial rescue mice, c2 restoration in Pv cells in
additional brain areas may also have happened, but the amount of
restored c2F77 protein may be too small to be detected by ligand
autoradiography (e.g. there is a faint transgene signal detected by
in situ hybridization in the colliculi, Figure 1C).
Altered tremor induction, reduced pain sensitivity and
sensorimotor impairment
The readout from behavioral and pharmacological experiments
with living mice is often from motor responses/activity, even
though a given test purports to measure e.g. anxiety or memory.
Therefore, the results from other tests have to be interpreted in the
light of baseline differences in motor functions.
There was slight tremor in both mouse model lines in the
observational test (Table 1), and therefore, we wanted to test
whether this feature would be exaggerated by the well-known
tremorogenic b-carboline compound harmaline [69]. The molec-
ular mechanism of action of harmaline is poorly known, but our
results indicate that it does not lose its efficacy in c2I77 mice that
lose the high-affinity binding for the b-carboline DMCM.
Interestingly, the harmaline-induced tremor in both Pv-Dc2 and
Pv-Dc2-partial rescue mice was altered from rather constant high-
amplitude tremor to more episodic low-amplitude activity. Thus, it
is possible that the Pv-cells in the well-known tremor pathway from
the inferior olivary nucleus to the cerebellar cortex are poorly
functioning in the mutants [70].
GABAA receptor a2/3 subunit-selective agonists have shown
promise as analgesics, highlighting the antinociceptive possibilities
of positive modulation of the receptor [71]. Both Pv-Dc2 and Pv-
Dc2-partial rescue mice had impaired pain sensitivity in the hot-
plate test that is usually interpreted to measure central rather than
spinal pain pathways [72]. The mouse lines demonstrated
unaltered latencies to thermal stimuli of the tail, which elicits a
quick reflexive flick. Pv-cells are present from the spinal cord to
cerebral cortex, giving many opportunities for modulation of pain
perception in Pv-Dc2 and Pv-Dc2-partial rescue mice, thus
making the localization(s) of the modulation difficult. In any case,
GABAergic neurons in the spinal lamina II contact pain-
conducting myelinated AD and unmyelinated C-fibers [73], and
pharmacological blockade of GABAA receptors produces tactile
allodynia [74]. If the overall GABAergic tone of the spinal cord is
increased in Pv-Dc2 mice due to increased activity of Pv-neurons,
pain sensitivity might consequently decrease. DMCM produced a
slight analgesic reaction in Pv-Dc2 mice, unlike in control c2I77
mice. As DMCM cannot exert its inverse agonistic effects
prevalent in wild-type c2F77 animals, it may have acted as a
positive modulator via the loreclezole site, where DMCM has a
clear agonistic action [33,75]. In the Pv-Dc2-partial rescue mice
the situation was different, as DMCM either produced a full
analgesic effect or failed to alter the latency of the tail flick at all
(Figure 8). Since DMCM induced a loss of muscle tone without
any reduction of spontaneous locomotor activity, a subset of the
Pv-Dc2-partial rescue mice might have been unable to produce
the normal nociceptive reflex. It is also possible that their sensory
perception had failed to register the pain when under the influence
of DMCM. As an alternative possibility, the cerebellum of Pv-
Dc2-partial rescue mice with its wild-type c2F77 subunit-
containing GABAA receptors, might mediate this abnormal
DMCM-induced antinociception.
The decreased PPI of acoustic startle we found in Pv-Dc2 and
Pv-Dc2-partial rescue mice points to a disruption of network
function at the inferior colliculus or thalamocortical level. It might
reflect a dysfunction of sensorimotor integration [76,77]. Impaired
PPI is present both in human schizophrenia patients [78,79] and
animal models of schizophrenia (for a review, see e.g. [80]), but we
failed to see any clear reduction of the impairment of PPI by the
antipsychotic drugs clozapine and haloperidol (Figure 5C). In
respect to defective PPI in Pv-Dc2 mice, it was notable that Pv-
Dc2-partial rescue mice were more sensitive to other behavioral
effects of the N-methyl-D-aspartate receptor antagonist MK-801,
although it could not enhance their defects in PPI (Figure 5D). The
mechanisms of this interesting pharmacological effect are
unknown. There is ample evidence for the potency of GABAA
agonistic benzodiazepines to attenuate the hyperactivity induced
by MK-801 and phencyclidine (another N-methyl-D-aspartate
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receptor antagonist) [81,82] and for the cortical Pv-interneurons
being an important target for MK-801 and phencyclidine actions
[83,84]. Thus, we suggest that abnormal Pv-neuron activity in Pv-
Dc2 mice has made the animals more vulnerable to toxic effects by
N-methyl-D-aspartate receptor antagonists.
Emotional and cognitive deficits: reduced anxiety and
impaired spatial memory
Pv cells that express GABAA receptors are found in many
amygdaloid nuclei [2,85], and also in the ventral hippocampus,
another brain region which contributes to emotional behavior
[86]. Indeed, knockout mice for the GABA synthesizing enzyme
glutamic acid decarboxylase 65 have increased anxiety [87].
Similarly, mice heterozygous for knockout of the c2 subunit gene,
or mice with a 65% knockdown of global c2 gene expression, have
increased anxiety levels [27,28], in agreement with less GABAer-
gic tone in the amygdala and other circuits. A possible increase in
the activity of Pv-interneurons in Pv-Dc2 and Pv-Dc2-partial
rescue mice would increase the overall GABAergic tone in the
amygdala, presumably leading to mice with less anxiety. This
response might correlate with the altered effects of 2 mM and
1 mM GABA on the anion channel binding site labeled by
[35S]TBPS in the central nucleus of amygdala of Pv-Dc2 and Pv-
Dc2-partial rescue mice, respectively (Figure 3B, Table S1).
Because of the strongly altered hippocampal oscillations in the
Pv-Dc2 mice [6], we predicted that the mice would show impaired
working memory; but our experiments using the spontaneous
alternation task showed no differences of the scores for Pv-Dc2 and
Pv-Dc2-partial rescue mice as compared with control c2I77 mice
(data not shown). These results were inconclusive as none of the
mouse lines performed well in this task (only about 50%
alternation), in contrast with several other control mouse lines
we have observed to perform consistently better [88]. On the other
hand, it took longer for both Pv-Dc2 and Pv-Dc2-partial rescue
mice to find the escape platform in the Morris water maze task,
and the latencies of the Pv-Dc2 mice were still much longer after 4
days of training. This poor learning could be seen as shorter times
spent in the platform quadrant in the probe trials. Hypothermia,
especially in frail gene-modified mice, might have impaired
learning in the water maze [89]; on the other hand, this is not
likely since the mice were quickly warmed up between trials.
Although in the probe trial the swimming speed of the mutant
mice did not differ from those of the controls, as discussed above a
part of the impaired learning could actually originate from deficits
in motor performance.
Conclusion
Given the huge diversity of Pv neurons and the neuronal circuits
in which they participate, it would be unrealistic to relate the
behavioral defects seen in the Pv-Dc2 and Pv-Dc2-partial rescue
mice to any one particular human neurological or psychiatric
disease. However, it is clear that c2 subunit-containing GABAA
receptors in Pv-positive cells, and by implication, fast synaptic
inhibition onto these cells is essential for normal brain function.
The processes we found defective are quite disparate: from
uncoupling of cortical network oscillations [6], reduced anxiety
through to impaired spatial memory to reduced pain sensitivity.
For the interpretation of behavioral experiments, this makes it
challenging to untangle cause and effect. Nevertheless, some of
these components could be separately investigated, perhaps using
knockout of c2 gene expression selectively in Pv-cells in particular
brain regions, such as we have already done for cerebellar Purkinje
cells [11,12].
Supporting Information
Table S1 Binding of [35S]TBPS in various brain areas of
c2I77 and Pv-Dc2 and Pv-Dc2-partial rescue (pr) mice in
the absence and presence of 2 mM and 1 mM GABA.
(DOC)
Acknowledgments
The authors thank Aira Sa¨isa¨, Philip Cobden, and David Roberts for
skillful technical assistance, Dr. Frank Zimmermann for BAC transgene
injections, Prof. Stephen Moss for the c2F77GFP cDNA, Dr. Elke Fuchs
and Prof. Hannah Monyer for the gift of the Pv BAC clone and PvCre
mouse line, and Prof. Peter Somogyi for evaluation and supervision of
certain aspects of the histological analyses as well as advice on the study.
Author Contributions
Conceived and designed the experiments: EL WS PW WW ERK.
Performed the experiments: EL A-ML OYV JDS HH PW. Analyzed the
data: EL VR ET JDS PW WW ERK. Wrote the paper: EL A-ML WW
ERK.
References
1. Tepper JM, Tecuapetla F, Koos T, Ibanez-Sandoval O (2010) Heterogeneity
and diversity of striatal GABAergic interneurons. Front Neuroanat 4: 150.
2. Woodruff AR, Sah P (2007) Networks of parvalbumin-positive interneurons in
the basolateral amygdala. J Neurosci 27: 553–563.
3. Celio MR (1990) Calbindin D-28k and parvalbumin in the rat nervous system.
Neuroscience 35: 375–475.
4. Meyer AH, Katona I, Blatow M, Rozov A, Monyer H (2002) In vivo labeling of
parvalbumin-positive interneurons and analysis of electrical coupling in
identified neurons. J Neurosci 22: 7055–7064.
5. Dougherty KJ, Sawchuk MA, Hochman S (2009) Phenotypic diversity and
expression of GABAergic inhibitory interneurons during postnatal development
in lumbar spinal cord of glutamic acid decarboxylase 67-green fluorescent
protein mice. Neuroscience 163: 909–919.
6. Wulff P, Ponomarenko AA, Bartos M, Korotkova TM, Fuchs EC, et al. (2009)
Hippocampal theta rhythm and its coupling with gamma oscillations require fast
inhibition onto parvalbumin-positive interneurons. Proc Natl Acad Sci U S A
106: 3561–3566.
7. Murray AJ, Sauer JF, Riedel G, McClure C, Ansel L, et al. (2011) Parvalbumin-
positive CA1 interneurons are required for spatial working but not for reference
memory. Nat Neurosci 14: 297–299.
8. Morris BJ, Cochran SM, Pratt JA (2005) PCP: from pharmacology to modelling
schizophrenia. Curr Opin Pharmacol 5: 101–106.
9. Fuchs EC, Zivkovic AR, Cunningham MO, Middleton S, Lebeau FE, et al.
(2007) Recruitment of parvalbumin-positive interneurons determines hippo-
campal function and associated behavior. Neuron 53: 591–604.
10. Korotkova T, Fuchs EC, Ponomarenko A, von Engelhardt J, Monyer H (2010)
NMDA receptor ablation on parvalbumin-positive interneurons impairs hippocam-
pal synchrony, spatial representations, and working memory. Neuron 68: 557–569.
11. Wulff P, Goetz T, Leppa E, Linden AM, Renzi M, et al. (2007) From synapse to
behavior: rapid modulation of defined neuronal types with engineered GABAA
receptors. Nat Neurosci 10: 923–929.
12. Wulff P, Schonewille M, Renzi M, Viltono L, Sassoe-Pognetto M, et al. (2009)
Synaptic inhibition of Purkinje cells mediates consolidation of vestibulo-
cerebellar motor learning. Nat Neurosci 12: 1042–1049.
13. Lewis DA, Hashimoto T, Volk DW (2005) Cortical inhibitory neurons and
schizophrenia. Nat Rev Neurosci 6: 312–324.
14. Klausberger T, Somogyi P (2008) Neuronal diversity and temporal dynamics:
the unity of hippocampal circuit operations. Science 321: 53–57.
15. Jinno S, Kosaka T (2004) Parvalbumin is expressed in glutamatergic and
GABAergic corticostriatal pathway in mice. J Comp Neurol 477: 188–201.
16. Lewis DA, Cruz DA, Melchitzky DS, Pierri JN (2001) Lamina-specific deficits in
parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects
with schizophrenia: evidence for fewer projections from the thalamus.
Am J Psychiatry 158: 1411–1422.
17. Rotaru DC, Barrionuevo G, Sesack SR (2005) Mediodorsal thalamic afferents to
layer III of the rat prefrontal cortex: synaptic relationships to subclasses of
interneurons. J Comp Neurol 490: 220–238.
18. Pritchett DB, Sontheimer H, Shivers BD, Ymer S, Kettenmann H, et al. (1989)
Importance of a novel GABAA receptor subunit for benzodiazepine pharma-
cology. Nature 338: 582–585.
Behaviour of Mice without Inhibition in Pv-Neurons
PLoS ONE | www.plosone.org 15 September 2011 | Volume 6 | Issue 9 | e24159
19. Wisden W, Laurie DJ, Monyer H, Seeburg PH (1992) The distribution of 13
GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon,
diencephalon, mesencephalon. J Neurosci 12: 1040–1062.
20. Seeburg PH, Wisden W, Verdoorn TA, Pritchett DB, Werner P, et al. (1990)
The GABAA receptor family: molecular and functional diversity. Cold Spring
Harbor Symp Quant Biol 55: 29–40.
21. Lorez M, Benke D, Luscher B, Mohler H, Benson JA (2000) Single-channel
properties of neuronal GABAA receptors from mice lacking the c2 subunit.
J Physiol 527: 11–31.
22. Schweizer C, Balsiger S, Bluethmann H, Mansuy IM, Fritschy JM, et al. (2003)
The c2 subunit of GABAA receptors is required for maintenance of receptors at
mature synapses. Mol Cell Neurosci 24: 442–450.
23. Essrich C, Lorez M, Benson JA, Fritschy JM, Luscher B (1998) Postsynaptic
clustering of major GABAA receptor subtypes requires the c2 subunit and
gephyrin. Nat Neurosci 1: 563–571.
24. Hevers W, Lu¨ddens H (1998) The diversity of GABAA receptors. Pharmaco-
logical and electrophysiological properties of GABAA channel subtypes. Mol
Neurobiol 18: 35–86.
25. Gu¨nther U, Benson J, Benke D, Fritschy JM, Reyes G, et al. (1995)
Benzodiazepine-insensitive mice generated by targeted disruption of the c2
subunit gene of c-aminobutyric acid type A receptors. Proc Natl Acad Sci U S A
92: 7749–7753.
26. Shen Q, Lal R, Luellen BA, Earnheart JC, Andrews AM, et al. (2010) c-
Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal
axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic
forms of depression. Biol Psychiatry 68: 512–520.
27. Crestani F, Lorez M, Baer K, Essrich C, Benke D, et al. (1999) Decreased
GABAA-receptor clustering results in enhanced anxiety and a bias for threat
cues. Nat Neurosci 2: 833–839.
28. Chandra D, Korpi ER, Miralles CP, De Blas AL, Homanics GE (2005) GABAA
receptor c2 subunit knockdown mice have enhanced anxiety-like behavior but
unaltered hypnotic response to benzodiazepines. BMC Neurosci 6: 30.
29. Earnheart JC, Schweizer C, Crestani F, Iwasato T, Itohara S, et al. (2007)
GABAergic control of adult hippocampal neurogenesis in relation to behavior
indicative of trait anxiety and depression states. J Neurosci 27: 3845–3854.
30. Lee K, Porteous R, Campbell RE, Luscher B, Herbison AE (2010) Knockdown
of GABAA receptor signaling in GnRH neurons has minimal effects upon
fertility. Endocrinology 151: 4428–4436.
31. Wallace RH, Marini C, Petrou S, Harkin LA, Bowser DN, et al. (2001) Mutant
GABAA receptor c2-subunit in childhood absence epilepsy and febrile seizures.
Nat Genet 28: 49–52.
32. Chiu C, Reid CA, Tan HO, Davies PJ, Single FN, et al. (2008) Developmental
impact of a familial GABAA receptor epilepsy mutation. Ann Neurol 64:
284–293.
33. Leppa E, Vekovischeva OY, Linden AM, Wulff P, Oberto A, et al. (2005)
Agonistic effects of the b-carboline DMCM revealed in GABAA receptor c2
subunit F77I point-mutated mice. Neuropharmacology 48: 469–478.
34. Cope DW, Wulff P, Oberto A, Aller MI, Capogna M, et al. (2004) Abolition of
zolpidem sensitivity in mice with a point mutation in the GABAA receptor c2
subunit. Neuropharmacology 47: 17–34.
35. Storb U, Pinkert C, Arp B, Engler P, Gollahon K, et al. (1986) Transgenic mice
with mu and kappa genes encoding antiphosphorylcholine antibodies. J Exp
Med 164: 627–641.
36. Nakazawa K, Quirk MC, Chitwood RA, Watanabe M, Yeckel MF, et al. (2002)
Requirement for hippocampal CA3 NMDA receptors in associative memory
recall. Science 297: 211–218.
37. Kittler JT, Wang J, Connolly CN, Vicini S, Smart TG, et al. (2000) Analysis of
GABAA receptor assembly in mammalian cell lines and hippocampal neurons
using c2 subunit green fluorescent protein chimeras. Mol Cell Neurosci 16:
440–452.
38. Yang XW, Model P, Heintz N (1997) Homologous recombination based
modification in Escherichia coli and germline transmission in transgenic mice of
a bacterial artificial chromosome. Nat Biotechnol 15: 859–865.
39. Wisden W, Morris BJ (1994) In situ hybridization with synthetic oligonucleotide
probes. In ‘In situ hybridization protocols for the brain’ Wisden, Morris, eds.
Academic Press, London. pp 9–34.
40. Korpi ER, Mihalek RM, Sinkkonen ST, Hauer B, Hevers W, et al. (2002)
Altered receptor subtypes in the forebrain of GABAA receptor d subunit-
deficient mice: recruitment of c2 subunits. Neuroscience 109: 733–743.
41. Ma¨kela¨ R, Uusi-Oukari M, Homanics GE, Quinlan JJ, Firestone LL, et al.
(1997) Cerebellar c-aminobutyric acid type A receptors: pharmacological
subtypes revealed by mutant mouse lines. Mol Pharmacol 52: 380–388.
42. Vekovischeva OY, Aitta-Aho T, Echenko O, Kankaanpaa A, Seppala T, et al.
(2004) Reduced aggression in AMPA-type glutamate receptor GluR-A subunit-
deficient mice. Genes Brain Behav 3: 253–265.
43. Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse.
Psychopharmacology (Berl) 92: 180–185.
44. Saarelainen KS, Ranna M, Rabe H, Sinkkonen ST, Moykkynen T, et al. (2008)
Enhanced behavioral sensitivity to the competitive GABA agonist, gaboxadol, in
transgenic mice over-expressing hippocampal extrasynaptic a6b GABAA
receptors. J Neurochem 105: 338–350.
45. Brody SA, Dulawa SC, Conquet F, Geyer MA (2004) Assessment of a prepulse
inhibition deficit in a mutant mouse lacking mGlu5 receptors. Mol Psychiatry 9:
35–41.
46. Heldt SA, Green A, Ressler KJ (2004) Prepulse inhibition deficits in GAD65
knockout mice and the effect of antipsychotic treatment. Neuropsychopharma-
cology 29: 1610–1619.
47. Haerich P, Nelson GA, Pecaut MJ (2005) HZE radiation and dopaminergic
modification of startle and prepulse inhibition in mice. Physiol Behav 86:
103–110.
48. Spooren W, Mombereau C, Maco M, Gill R, Kemp JA, et al. (2004)
Pharmacological and genetic evidence indicates that combined inhibition of
NR2A and NR2B subunit containing NMDA receptors is required to disrupt
prepulse inhibition. Psychopharmacology (Berl) 175: 99–105.
49. Florian C, Roullet P (2004) Hippocampal CA3-region is crucial for acquisition
and memory consolidation in Morris water maze task in mice. Behav Brain Res
154: 365–374.
50. Korpi ER, Koikkalainen P, Vekovischeva OY, Makela R, Kleinz R, et al. (1999)
Cerebellar granule-cell-specific GABAA receptors attenuate benzodiazepine-
induced ataxia: evidence from a6-subunit-deficient mice. Eur J Neurosci 11:
233–240.
51. Linden AM, Aller MI, Leppa E, Rosenberg PH, Wisden W, et al. (2008) K+
channel TASK-1 knockout mice show enhanced sensitivities to ataxic and
hypnotic effects of GABAA receptor ligands. J Pharmacol Exp Ther 327:
277–286.
52. Wisden W, Murray AJ, McClure C, Wulff P (2009) Studying cerebellar circuits
by remote control of selected neuronal types with GABAA receptors. Front Mol
Neurosci 2: 29.
53. Ogris W, Poltl A, Hauer B, Ernst M, Oberto A, et al. (2004) Affinity of various
benzodiazepine site ligands in mice with a point mutation in the GABAA
receptor c2 subunit. Biochem Pharmacol 68: 1621–1629.
54. Linden AM, Schmitt U, Leppa E, Wulff P, Wisden W, et al. (2011) Ro 15-4513
antagonizes alcohol-induced sedation in mice through abc2-type GABAA
receptors. Front Neurosci 5: 3.
55. Leppa¨ E, Linden AM, Rabe H, Vekovischeva OY, Wulff P, et al. (2011) Actions
of two GABAA receptor benzodiazepine-site ligands that are mediated via non-
c2-dependent modulation. Eur J Pharmacol 666: 111–121.
56. Sinkkonen ST, Luscher B, Luddens H, Korpi ER (2004) Autoradiographic
imaging of altered synaptic abc2 and extrasynaptic ab GABAA receptors in a
genetic mouse model of anxiety. Neurochem Int 44: 539–547.
57. Halonen LM, Sinkkonen ST, Chandra D, Homanics GE, Korpi ER (2009)
Brain regional distribution of GABAA receptors exhibiting atypical GABA
agonism: roles of receptor subunits. Neurochem Int 55: 389–396.
58. Maksay G, Simonyi M (1986) Kinetic regulation of convulsant (TBPS) binding
by GABAergic agents. Mol Pharmacol 30: 321–328.
59. Luddens H, Korpi ER (1995) GABA antagonists differentiate between
recombinant GABAA/benzodiazepine receptor subtypes. J Neurosci 15:
6957–6962.
60. Llinas R, Yarom Y (1986) Oscillatory properties of guinea-pig inferior olivary
neurones and their pharmacological modulation: an in vitro study. J Physiol 376:
163–182.
61. Milner TE, Cadoret G, Lessard L, Smith AM (1995) EMG analysis of
harmaline-induced tremor in normal and three strains of mutant mice with
Purkinje cell degeneration and the role of the inferior olive. J Neurophysiol 73:
2568–2577.
62. Cone RD, Cowley MA, Butler AA, Fan W, Marks DL, et al. (2001) The arcuate
nucleus as a conduit for diverse signals relevant to energy homeostasis. Int J Obes
Relat Metab Disord 25 Suppl 5: S63–67.
63. Wu Q, Boyle MP, Palmiter RD (2009) Loss of GABAergic signaling by AgRP
neurons to the parabrachial nucleus leads to starvation. Cell 137: 1225–1234.
64. Reddy DS, Kulkarni SK (1998) The role of GABAA and mitochondrial
diazepam-binding inhibitor receptors on the effects of neurosteroids on food
intake in mice. Psychopharmacology (Berl) 137: 391–400.
65. Alvarez FJ, Jonas PC, Sapir T, Hartley R, Berrocal MC, et al. (2005) Postnatal
phenotype and localization of spinal cord V1 derived interneurons. J Comp
Neurol 493: 177–192.
66. Goulding M (2009) Circuits controlling vertebrate locomotion: moving in a new
direction. Nat Rev Neurosci 10: 507–518.
67. Taft WC, DeLorenzo RJ (1984) Micromolar-affinity benzodiazepine receptors
regulate voltage-sensitive calcium channels in nerve terminal preparations. Proc
Natl Acad Sci U S A 81: 3118–3122.
68. Takahashi H, Yoshimoto M, Higuchi H, Shimizu T, Hishikawa Y (1999)
Different effects of L-type and T-type calcium channel blockers on the hypnotic
potency of triazolam and zolpidem in rats. Eur Neuropsychopharmacol 9:
317–321.
69. Mehta H, Saravanan KS, Mohanakumar KP (2003) Serotonin synthesis
inhibition in olivo-cerebellar system attenuates harmaline-induced tremor in
Swiss albino mice. Behav Brain Res 145: 31–36.
70. Llinas R, Volkind RA (1973) The olivo-cerebellar system: functional properties
as revealed by harmaline-induced tremor. Exp Brain Res 18: 69–87.
71. Zeilhofer HU, Witschi R, Hosl K (2009) Subtype-selective GABAA receptor
mimetics–novel antihyperalgesic agents? J Mol Med 87: 465–469.
72. Caggiula AR, Epstein LH, Perkins KA, Saylor S (1995) Different methods of
assessing nicotine-induced antinociception may engage different neural mech-
anisms. Psychopharmacology (Berl) 122: 301–306.
73. Heinke B, Ruscheweyh R, Forsthuber L, Wunderbaldinger G, Sandkuhler J
(2004) Physiological, neurochemical and morphological properties of a subgroup
Behaviour of Mice without Inhibition in Pv-Neurons
PLoS ONE | www.plosone.org 16 September 2011 | Volume 6 | Issue 9 | e24159
of GABAergic spinal lamina II neurones identified by expression of green
fluorescent protein in mice. J Physiol 560: 249–266.
74. Sivilotti L, Woolf CJ (1994) The contribution of GABAA and glycine receptors to
central sensitization: disinhibition and touch-evoked allodynia in the spinal cord.
J Neurophysiol 72: 169–179.
75. Stevenson A, Wingrove PB, Whiting PJ, Wafford KA (1995) b-Carboline
gamma-aminobutyric acidA receptor inverse agonists modulate c-aminobutyric
acid via the loreclezole binding site as well as the benzodiazepine site. Mol
Pharmacol 48: 965–969.
76. Bakshi VP, Swerdlow NR, Geyer MA (1994) Clozapine antagonizes phency-
clidine-induced deficits in sensorimotor gating of the startle response.
J Pharmacol Exp Ther 271: 787–794.
77. Yamashita M, Fukushima S, Shen HW, Hall FS, Uhl GR, et al. (2006)
Norepinephrine transporter blockade can normalize the prepulse inhibition
deficits found in dopamine transporter knockout mice. Neuropsychopharma-
cology 31: 2132–2139.
78. Ludewig K, Geyer MA, Vollenweider FX (2003) Deficits in prepulse inhibition
and habituation in never-medicated, first-episode schizophrenia. Biol Psychiatry
54: 121–128.
79. Hong LE, Summerfelt A, Wonodi I, Adami H, Buchanan RW, et al. (2007)
Independent domains of inhibitory gating in schizophrenia and the effect of
stimulus interval. Am J Psychiatry 164: 61–65.
80. Swerdlow NR, Weber M, Qu Y, Light GA, Braff DL (2008) Realistic
expectations of prepulse inhibition in translational models for schizophrenia
research. Psychopharmacology (Berl) 199: 331–388.
81. Bradford AM, Savage KM, Jones DN, Kalinichev M (2010) Validation and
pharmacological characterisation of MK-801-induced locomotor hyperactivity
in BALB/C mice as an assay for detection of novel antipsychotics.
Psychopharmacology (Berl) 212: 155–170.
82. Fahey JM, Pritchard GA, Pratt JS, Shader RI, Greenblatt DJ (1999) Lorazepam
attenuates the behavioral effects of dizocilpine. Pharmacol Biochem Behav 62:
103–110.
83. Pratt JA, Winchester C, Egerton A, Cochran SM, Morris BJ (2008) Modelling
prefrontal cortex deficits in schizophrenia: implications for treatment.
Br J Pharmacol 153 Suppl 1: S465–470.
84. Wang CZ, Yang SF, Xia Y, Johnson KM (2008) Postnatal phencyclidine
administration selectively reduces adult cortical parvalbumin-containing inter-
neurons. Neuropsychopharmacology 33: 2442–2455.
85. McDonald AJ, Mascagni F (2004) Parvalbumin-containing interneurons in the
basolateral amygdala express high levels of the a1 subunit of the GABAA
receptor. J Comp Neurol 473: 137–146.
86. Fanselow MS, Dong HW (2010) Are the dorsal and ventral hippocampus
functionally distinct structures? Neuron 65: 7–19.
87. Kash SF, Tecott LH, Hodge C, Baekkeskov S (1999) Increased anxiety and
altered responses to anxiolytics in mice deficient in the 65-kDa isoform of
glutamic acid decarboxylase. Proc Natl Acad Sci U S A 96: 1698–1703.
88. Linden AM, Sandu C, Aller MI, Vekovischeva OY, Rosenberg PH, et al. (2007)
TASK-3 knockout mice exhibit exaggerated nocturnal activity, impairments in
cognitive functions, and reduced sensitivity to inhalation anesthetics. J Pharmacol
Exp Ther 323: 924–934.
89. Iivonen H, Nurminen L, Harri M, Tanila H, Puoliva¨li J (2003) Hypothermia in
mice tested in Morris water maze. Behav Brain Res 141: 207–213.
Behaviour of Mice without Inhibition in Pv-Neurons
PLoS ONE | www.plosone.org 17 September 2011 | Volume 6 | Issue 9 | e24159
